Orchid Pharma (NSE:ORCHPHARMA) Accounts Payable & Accrued Expense : ₹2,296 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Accounts Payable & Accrued Expense?

Orchid Pharma's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹2,254 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹2,296 Mil).

Orchid Pharma's annual accounts payable & accrued expense increased from Mar. 2022 (₹1,682 Mil) to Mar. 2023 (₹1,827 Mil) and increased from Mar. 2023 (₹1,827 Mil) to Mar. 2024 (₹2,296 Mil).

Orchid Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Orchid Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Accounts Payable & Accrued Expense Chart

Orchid Pharma Annual Data

Trend

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,015.89

1,124.81

1,682.09

1,827.38

2,295.77

Orchid Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,827.38	-	2,253.72	-	2,295.77

Orchid Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Orchid Pharma (NSE:ORCHPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

524372:India

Address

313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines